🇺🇸 FDA
Pipeline program

627

SSGJ-627-UC-II-01

Phase 2 small_molecule active

Quick answer

627 for Ulcerative Colitis (UC) is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Ulcerative Colitis (UC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials